login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 




Featured Highlights
11 - 30 of 147   Items

Surefire system vs. end hole catheter clinical trial eliminates patient variables

Monday, 05 May 2014
Preliminary observations from the trial were presented at the Global Embolization Symposium and Technologies US (GEST US meeting, 1–4 May, San Francisco, USA) and show increased tumour penetration with the Surefire system. Surefire system vs. end hole catheter clinical trial eliminates patient variables
Interventional radiology techniques and results for the management of neuroendocrine liver metastases

Interventional radiology techniques and results for the management of neuroendocrine liver metastases

Wednesday, 30 Apr 2014
Interventional radiology techniques are widely performed and useful in liver metastases from neuroendocrine tumours, but the level of scientific proof is paradoxically low, especially when considering that these techniques are used in patients with cancer, write Maxime Ronot and Valérie Vilgrain Interventional radiology techniques and results for the management of neuroendocrine liver metastases
COSY trial shows highly reduced radioembolization procedure time and radiation dose

COSY trial shows highly reduced radioembolization procedure time and radiation dose

Friday, 28 Mar 2014
Surefire Medical has announced that the COSY clinical trial (Coiling vs. Surefire infusion system in Y90) showed significant reductions in fluoroscopy time, procedure time, radiation dose and contrast dose when using the Surefire Infusion System without coiling. COSY trial shows highly reduced radioembolization procedure time and radiation dose

Sirtex and Guerbet announce collaboration in clinical studies in liver cancer

Thursday, 27 Mar 2014
Sirtex and Guerbet have announced that the two companies are entering into a collaboration to advance research in primary and secondary metastatic liver cancer. Sirtex and Guerbet announce collaboration in clinical studies in liver cancer

Cancer specialists to head to Berlin to attend ECIO

Thursday, 27 Mar 2014
The world’s leading radiologists, oncologists and surgeons will head to Germany in April for the European Conference on International Oncology (ECIO, 23-26 April, Berlin, Germany). Cancer specialists to head to Berlin to attend ECIO
Radioembolization offers new, safe treatment for metastatic breast cancer

Radioembolization offers new, safe treatment for metastatic breast cancer

Monday, 24 Mar 2014
The largest study of its kind to date shows that minimally invasive radioembolization may slow metastatic disease progression in liver when no other treatment options remain, according to research being presented at the Society of Interventional Radiology’s 39th Annual Scientific Meeting (22–27 March, San Diego, USA). Radioembolization offers new, safe treatment for metastatic breast cancer
Safety and efficacy of percutaneous cryoablation in renal cell carcinoma in 2014

Safety and efficacy of percutaneous cryoablation in renal cell carcinoma in 2014

Thursday, 27 Feb 2014
The outcomes from our study on the efficacy and safety of percutaneous cryoablation, published recently in CardioVascular and Interventional Radiology (CVIR), are the result of the most rigorous investigation on the subject to-date. These exceptional numbers, however, are a double-edged sword. On one hand, they approach those of the gold standard, on the other, we must prove they are widely reproducible, writes Christos Georgiades Safety and efficacy of percutaneous cryoablation in renal cell carcinoma in 2014
MORE study data provide insight into predicting SIRT treatment outcomes

MORE study data provide insight into predicting SIRT treatment outcomes

Thursday, 23 Jan 2014
Investigators from the MORE (Metastatic colorectal cancer liver metastases outcomes after radioembolization) study have released new findings at the American Society of Clinical Oncology’s 2014 Gastrointestinal Cancers Symposium confirming that standard laboratory tests are a valuable tool for predicting patient outcomes prior to Selective Internal Radiation Therapy (SIRT). MORE study data provide insight into predicting SIRT treatment outcomes
Cryoablation provides pain relief for patients with metastatic tumours

Cryoablation provides pain relief for patients with metastatic tumours

Sunday, 19 Jan 2014
Cryoablation kills tumours and provides pain relief to patients whose cancer has spread to the bone and soft tissue, suggests research being presented at the 6th annual Symposium on Clinical Interventional Oncology (CIO), in collaboration with the International Symposium on Endovascular Therapy (ISET). Cryoablation provides pain relief for patients with metastatic tumours
Ten-year Spanish experience shows SIRT achieves disease control in over 80% hepatocellular carcinoma patients

Ten-year Spanish experience shows SIRT achieves disease control in over 80% hepatocellular carcinoma patients

Tuesday, 14 Jan 2014
The Clínica Universidad de Navarra (CUN), Pamplona, Spain, recently celebrated its tenth anniversary of using Yttrium-90 (Y-90) microsphere radioembolization for the treatment of liver cancer. Ten-year Spanish experience shows SIRT achieves disease control in over 80% hepatocellular carcinoma patients
Effectiveness of percutaneous cryoablation for stage IA/B renal cell carcinoma approaches that of gold standard, surgery

Effectiveness of percutaneous cryoablation for stage IA/B renal cell carcinoma approaches that of gold standard, surgery

Monday, 13 Jan 2014
A prospective single-arm, five-year study has found that CT-guided percutaneous cryoablation for renal cell carcinoma offers very high efficacy, approaching that of the gold standard, surgery. Cryoablation also has a more favourable safety profile. Effectiveness of percutaneous cryoablation for stage IA/B renal cell carcinoma approaches that of gold standard, surgery

Launch of Hepatic Oncology: a journal dedicated to the management of cancers of the liver

Friday, 10 Jan 2014
Future Medicine Ltd has announced the launch of a new journal, Hepatic Oncology. This new title focuses specifically on the specialism of hepatic cancer, including both primary and secondary malignancies. Launch of Hepatic Oncology: a journal dedicated to the management of cancers of the liver
Interventional oncologists begin running US National Cancer Institute cooperative group trial

Interventional oncologists begin running US National Cancer Institute cooperative group trial

Friday, 20 Dec 2013
An important opportunity has opened up for interventional oncologists as WCIO leaders take the helm of the E1208 trial. Michael C Soulen writes that the change in the trial leadership from medical oncology to interventional oncology represents a challenge because it rests on the question: can interventional oncologists run a successful cooperative group trial of image-guided therapy? Interventional oncologists begin running US National Cancer Institute cooperative group trial
Surefire Medical completes patient enrolment in COSY trial

Surefire Medical completes patient enrolment in COSY trial

Wednesday, 11 Dec 2013
The trial evaluates eliminating coiling by using the anti-reflux Surefire Infusion System in radioembolization procedures in liver cancer. Surefire Medical completes patient enrolment in COSY trial

FDA grants Orphan Drug Designation to Lipiodol injection for management of patients with known hepatocellular carcinoma

Tuesday, 22 Oct 2013
Guerbet has announced that it has been granted Orphan Drug Designation from the US Food and Drug Administration Office of Orphan Products Development (OOPD) for Lipiodol (ethiodised oil) injection for management of patients with known hepatocellular carcinoma. FDA grants Orphan Drug Designation to Lipiodol injection for management of patients with known hepatocellular carcinoma
NHS England makes selective internal radiation therapy (SIRT) available via new commissioning procedure

NHS England makes selective internal radiation therapy (SIRT) available via new commissioning procedure

Wednesday, 02 Oct 2013
The NHS revision of Clinical Policy Commissioning Statement on SIRT will allow patients in England with metastatic colorectal cancer and intrahepatic cholangiocarcinoma who may benefit from the therapy to get treatment in specialist NHS centres. NHS England makes selective internal radiation therapy (SIRT) available via new commissioning procedure

AngioDynamics highlighted new offerings at CIRSE 2013

Friday, 20 Sep 2013
Angiovac cannula and cardiopulmonary bypass circuit, Bioflo peripherally inserted central catheters, Nanoknife system, Nevertouch direct fibre and Acculis microwave system illustrate strength of company’s portfolio. AngioDynamics highlighted new offerings at CIRSE 2013
Benefits of thermal ablation in the lung in conjunction with other therapies “cannot be overstated”

Benefits of thermal ablation in the lung in conjunction with other therapies “cannot be overstated”

Friday, 23 Aug 2013
Thomas Vogl, Institute of Diagnostic and Interventional Radiology, Goethe University, Frankfurt, spoke at ECIO (19–22 June, Budapest Hungary) about novel lung ablative techniques and the evidence for combination ablative therapies. Benefits of thermal ablation in the lung in conjunction with other therapies “cannot be overstated”
ThermoDox HEAT study results to be presented at ILCA 2013

ThermoDox HEAT study results to be presented at ILCA 2013

Thursday, 22 Aug 2013
The presentation will include the most recent overall survival data. Recent HEAT study post-hoc analysis, strongly suggest positive progression-free survival and overall survival in ThermoDox treated patients when heating cycles from the radiofrequency ablation procedure were optimised. ThermoDox HEAT study results to be presented at ILCA 2013
Tumour measurements predict survival in advanced non-small cell lung cancer

Tumour measurements predict survival in advanced non-small cell lung cancer

Wednesday, 21 Aug 2013
For the two-thirds of lung cancer patients with locally advanced or metastatic disease, tumour size is not used currently to predict overall survival times. A new study, however, led by UT Southwestern Medical Center researchers has shown that even in advanced stages, total tumour size can have a major impact on survival. Tumour measurements predict survival in advanced non-small cell lung cancer
Found: 147   Displaying: 11-30
Results: 1 2 3 4 5 Next Go to:

Related Section


Clinical Trials
Interventional Oncology News
Interventional Oncology Supplement
Key Opinion Leaders discuss the role of Biocompatible's DC Bead at CIRSE and ILCA
IR Views
Literature
Oncology Useful Links

Related Feeds


Most popular


ROADSTER trial studying new path to carotid revascularisation completes patient enrolment
Friday, 18 Jul 2014
The trial was the first of its kind to study the treatment of carotid artery stenosis by placing a stent via direct access to the common carotid artery in the neck in an entirely new minimally ... ROADSTER trial studying new path to carotid revascularisation completes patient enrolment

Robot-assisted uterine artery embolization is feasible and safe, study finds
Friday, 11 Jul 2014
A study published online ahead of print in July in the Journal of Vascular and Interventional Radiology (JVIR) provides a technical description of robot-assisted uterine artery embolization and ... Robot-assisted uterine artery embolization is feasible and safe, study finds

Endovascular-first strategy for aortoiliac lesions irrespectively of TASC category
Thursday, 17 Jul 2014
Two-year data from a prospective, multicentre study suggest that endovascular therapy with stenting may be considered the preferred first-line treatment option for aortoiliac lesions, irrespectively ... Endovascular-first strategy for aortoiliac lesions irrespectively of TASC category

Features


Is all heat the same and does catheter design matter?
Wednesday, 13 Aug 2014
Mark S Whiteley writes that it is essential that every doctor practising varicose vein surgery has a good understanding of the principles of endovenous thermoablation. Is all heat the same and does catheter design matter?

The 11th Scientific Meeting of the Chinese Society of Interventional Radiology successfully held in Changsha
Tuesday, 08 Jul 2014
The 11th Scientific Meeting of the Chinese Society of Interventional Radiology (2014 CSIR) was held from 11–15 June 2014 in Changsha, Hunan Province, China. The Chinese Society of Interventional R... The 11th Scientific Meeting of the Chinese Society of Interventional Radiology successfully held in Changsha

Profiles


Bien Soo Tan
Friday, 16 May 2014
Bien Soo Tan, senior consultant, Department of Diagnostic Radiology, Singapore General Hospital, S... Bien Soo Tan

James B Spies
Friday, 16 May 2014
The evolution of embolization over the past decade has been remarkable and it has fundamentally ... James B Spies

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions